Literature DB >> 32305474

Effect of PCSK-9 Inhibitors on Lipid-Rich Vulnerable Coronary Plaque Assessed by Near-Infrared Spectroscopy.

Hiroyuki Omori, Hideaki Ota, Masahiko Hara, Yoshiaki Kawase, Toru Tanigaki, Tetsuo Hirata, Yoshihiro Sobue, Munenori Okubo, Hiroki Kamiya, Hitoshi Matsuo.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32305474     DOI: 10.1016/j.jcmg.2020.02.019

Source DB:  PubMed          Journal:  JACC Cardiovasc Imaging        ISSN: 1876-7591


× No keyword cloud information.
  5 in total

1.  CENIT (Impact of Cardiac Exercise Training on Lipid Content in Coronary Atheromatous Plaques Evaluated by Near-Infrared Spectroscopy): A Randomized Trial.

Authors:  Elisabeth Kleivhaug Vesterbekkmo; Erik Madssen; Inger-Lise Aamot Aksetøy; Turid Follestad; Hans Olav Nilsen; Knut Hegbom; Ulrik Wisløff; Rune Wiseth
Journal:  J Am Heart Assoc       Date:  2022-05-16       Impact factor: 6.106

2.  Impact of PCSK9 Inhibition on Proinflammatory Cytokines and Matrix Metalloproteinases Release in Patients with Mixed Hyperlipidemia and Vulnerable Atherosclerotic Plaque.

Authors:  Marcin Basiak; Michal Kosowski; Marcin Hachula; Boguslaw Okopien
Journal:  Pharmaceuticals (Basel)       Date:  2022-06-27

3.  Impact of Alirocumab on Release Markers of Atherosclerotic Plaque Vulnerability in Patients with Mixed Hyperlipidemia and Vulnerable Atherosclerotic Plaque.

Authors:  Michał Kosowski; Marcin Basiak; Marcin Hachuła; Bogusław Okopień
Journal:  Medicina (Kaunas)       Date:  2022-07-21       Impact factor: 2.948

Review 4.  Pleiotropic Effects of PCSK-9 Inhibitors.

Authors:  Marcin Basiak; Michał Kosowski; Marcin Cyrnek; Łukasz Bułdak; Mateusz Maligłówka; Grzegorz Machnik; Bogusław Okopień
Journal:  Int J Mol Sci       Date:  2021-03-19       Impact factor: 5.923

Review 5.  Insight into the Evolving Role of PCSK9.

Authors:  Mateusz Maligłówka; Michał Kosowski; Marcin Hachuła; Marcin Cyrnek; Łukasz Bułdak; Marcin Basiak; Aleksandra Bołdys; Grzegorz Machnik; Rafał Jakub Bułdak; Bogusław Okopień
Journal:  Metabolites       Date:  2022-03-17
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.